96450 ⎘
Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane; Androstane derivatives substituted in position 17 by a keto group
Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure
#2NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#3COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#4A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF
#5METHOD OF PREPARING ESTRADIOL DERIVATIVES BY SOLID-PHASE SYNTHESIS
#6NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF
#7NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#8Compositions and methods for treating CNS disorders
#9Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure.
#10Compositions and methods for treating CNS disorders
#11COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#12Small molecules active against gram-negative bacteria
#13Methods for Preparing Bile Acids
#14Neuroactive steroids, compositions, and uses thereof
#15COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
#16Bio-catalyzed Synthesis of New Aromatase Inhibitors through Structural Modifications of Anticancer Drug Formestane
#17NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#18Ultrasonic-assisted pretreatment method for extraction of multiple steroid hormones in sediment
#19Neuroactive steroids, compositions, and uses thereof
#20Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#21Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#22Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
#23CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES
#24Compositions and methods for treating CNS disorders
#25Methods for preparing bile acids
#26Preparation of bile acids and intermediates thereof
#27Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
#28C-HALOGEN BOND FORMATION
#29NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#30Methods for the purification of deoxycholic acid
#31Neuroactive steroids, compositions, and uses thereof
#32Neuroactive steroids, compositions, and uses thereof
#33Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#34Methods for the purification of deoxycholic acid
#35Small molecules active against gram-negative bacteria
#36C-HALOGEN BOND FORMATION
#37METHODS FOR PREPARING DEOXYCHOLIC ACID
#38Preparation of bile acids and intermediates thereof
#39Steroidal compound, composition containing the same and use thereof
#40Methods for preparation of bile acids and derivatives thereof
#41Neuroactive steroids, compositions, and uses thereof
#42Methods for preparing deoxycholic acid
#43Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
#44Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
#45Methods for the purification of deoxycholic acid
#46Neuroactive steroids, compositions, and uses thereof
#47Compositions and methods for treating CNS disorders
#48Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
#49Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
#50Use of certain transition metal hyperaccumulator plants for reducing organic compounds in a green manner
#51Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
#52Method For DHEA Enanthate Processing
#53Method For DHEA Enanthate Processing
#54Method for preparing abiraterone acetate
#55Processes for the preparation of dehydroepiandrosterone and its intermediates
#56Inhibitors of CYP17A1
#57NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION
#58Process for the preparation of unsaturated trifluoromethanesulfonate steroid derivatives
#59Preparation of bile acids and intermediates thereof
#60Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
#61Methods for the purification of deoxycholic acid
#62Process for alkynylating 16-substituted-17-keto steroids
#63Process for the preparation of abiraterone and intermediates thereof
#64Methods for stereoselective reduction
#65Dosage form to increase prasterone bioavailability
#66Cocrystalline DHEA formulations
#67Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
#68Asymmetric synthesis of organic compounds
#69C-halogen bond formation
#70Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
#71Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
#72C-HALOGEN BOND FORMATION
#73Chemoselective enrichment for compound isolation
#74Steroids having increased water solubility and resistance against metabolism, and methods for their production
#75Contraceptive agents
#76Steroids having increased water solubility and resistance against metabolism and methods for their production
#77PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF
#78Substituted androst-4-ene diones
#79Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their Production
#80New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their Production
#81Ship inhibitors and uses thereof
#82Chemoselective enrichment for compound isolation
#83MODULATORS OF AMYLOID-BETA PRODUCTION
#84Dosage form to increase prasterone bioavailability
#85METHODS AND COMPOUNDS FOR PREPARING 3ALPHA-OXYGEN SUBSTITUTED STEROIDS
#86Exemestane and its intermediates and methods of making the same
#87Steroid compounds and treatment methods
#88Preparation of bile acids and intermediates thereof
#89Preparation of bile acids and intermediates thereof
#90PROCESS FOR OBTAINING 6-ALKYLIDENANDROST-1, 4-DIENE-3-ONE
#91Steroid compounds and formulations
#925a-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR
#93Unsaturated Steroid Compounds
#94Methods for stereoselective reduction
#95Compounds and compositions
#96Process for preparing aromatiase inhibitor exemestane
#97Cancer treatment methods
#98Pharmaceutical compositions-4
#99Preparation of bile acids and intermediates thereof
#100NOVEL COMPOUNDS
#101Preparation of bile acids and intermediates thereof
#102MODULATORS OF AMYLOID-BETA PRODUCTION
#103Preparation of bile acids and intermediates thereof
#104Process for production of steroid compound
#105Pharmaceutical Compositions - 2
#106Diene and triene compounds and formulations
#107Diene compounds and formulations
#108Androsterone Derivatives and Method of Use thereof
#109Allylic oxidations catalyzed by dirhodium catalysts under aqueous conditions
#110Crystalline polymorph of exemestane
#111Process for preparing aromatase inhibitors
#112Exemestane and its intermediates and methods of making the same
#113Process for the preparation of 17-hydroxy-6β,7β;15β,16β-bismethylene-17α-pregn-4-ene-3-one-21-carboxylic acid γ-lactone and key intermediates for this process
#114Pharmaceutical compositions 3
#115Breast and prostate cancer treatment method
#116Steroids having increased water solubility and resistance against metabolism, and methods for their production
#117Prostate cancer treatment
#118Glucocorticosteroid compound having anti-inflammatory activity
#119Formulations
#120Pharmaceutical Compositions
#121Novel compounds
#122Pharmaceutical compositions
#123Compounds
#124Prostate cancer treatment
#125Steroids having 1,8-unsaturation and formulations comprising same
#126Formulations and Treatment Methods
#127Pharmaceutical treatments and compositions
#128Process for preparing guggulsterones and guggulsterol
#129Specific glucocorticosteroid compound having anti-inflammatory activity
#130Specific glucocorticosteroid compound having anti-inflammatory activity
#1316,7-Oxygenated steroids and uses related thereto
#132Tetrol steroids and esters
#133Pharmaceutical compositions and treatment methods-7
#134Asthma and colitis treatment methods
#1357-Oxo-DHEA compounds for treating keratinous conditions/afflictions
#136Pharmaceutical compositions and treatment methods - 8
#137Neurological disorder treatment methods